Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Tegoprazan and Amoxicillin/Clarithromycin in Healthy Subjects
NCT03011996Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- May 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan in Helicobacter pylori infection (5 arms), sponsored by HK inno.N Corporation. Primary endpoint: Peak Plasma Concentration up to 120 hours. Started May 2016; status: completed.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03011996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011996.